CHAM
LFCR icon

Clear Harbor Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Clear Harbor Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-250
Closed -$2.43K – 542
2020
Q3 		$2.43K Buy
+250
New +$2.38K ﹤0.01% 719
2020
Q1 		– Sell
-250
Closed -$2.83K – 505
2019
Q4 		$2.83K Buy
+250
New +$2.66K ﹤0.01% 715

Other funds holding LFCR

LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Clear Harbor Asset Management's LFCR Position: Q4 2020 in Review

Clear Harbor Asset Management sold out of Lifecore Biomedical (LFCR) in Q4 2020, closing a stake of 250 shares — an estimated $2.43K sold.

Clear Harbor Asset Management first reported a position in LFCR in Q4 2019 and held it in 2 quarters. The position peaked at $2.83K in Q4 2019. 96 funds tracked by Wall St. Rank hold LFCR as of Q4 2020.

  • Clear Harbor Asset Management reported no remaining Lifecore Biomedical position as of Q4 2020 after selling out during the quarter.
  • Clear Harbor Asset Management sold 250 Lifecore Biomedical shares in Q4 2020, an estimated $2.43K.
  • Clear Harbor Asset Management first reported a position in Lifecore Biomedical in Q4 2019 and held it in 2 quarters.
  • Clear Harbor Asset Management's Lifecore Biomedical position peaked at $2.83K in Q4 2019.
  • 96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2020.

Based on Clear Harbor Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.